已收盤 11-20 16:00:00 美东时间
-0.059
-10.98%
Valion Bio ( ($VBIO) ) has shared an update. On October 27, 2026, Valion Bio no...
11-02 21:19
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation, today announced that it has received unsolicited acquisition inquiries from independent third par...
10-26 20:03
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation, today highlighted the capabilities of its wholly owned contract development and manufacturing org...
10-14 20:19
An update from Valion Bio ( ($VBIO) ) is now available. On October 7, 2026, Val...
10-08 18:29
Valion Bio shares are trading higher after the company announced the completion of formulation work under the company's ongoing program to develop a novel oral mucosal formulation of Entolimod with Shear Kershman Laboratories.
10-01 02:08
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company, today announced decisive changes to its executive leadership team and Board of Directors (the "Board"). These leadership transitions are intended to strengthen organizational alignment and support...
09-23 20:02
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company, today announced strategic changes to its management team and Board of Directors designed to accelerate execution across its clinical and commercial initiatives and position the Company for its nex...
09-01 20:09
The latest update is out from Valion Bio ( ($VBIO) ). On August 31, 2026, Valio...
09-01 18:29
Valion Bio, Inc. (Nasdaq:VBIO) ("Valion Bio" or the "Company) announced today that its Board of Directors has declared a 1-for-25 reverse stock split of the Company's issued and outstanding shares of common stock. The purpose of the reverse stock split is to bring the Company into compliance with th...
08-27 20:32
Shares of Cadeler A/S – ADR (NYSE:CDLR) rose sharply in pre-market trading after the company reported interim financial results for the first half of 2026. Revenue for the first six months of 2026 jumped to EUR 408 million from EUR 188 million in the year-ago period. Profit for the period climbed 54...
08-25 17:25